Norbert Grząśko
机构：Medical University of Lublin · ORCID：0000-0001-7727-4307
发表论文 87 篇 · 总被引 2453 次 · h-index 20
代表论文
- Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (2021 · Journal of Clinical Oncology · 被引 100)
- Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321) (2025 · Journal of Clinical Oncology · 被引 39)
- A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma (2020 · American Journal of Hematology · 被引 30)
- BRUIN CLL-321: Randomized Phase III Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab (IdelaR) or Bendamustine Plus Rituximab (BR) in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (2024 · Blood · 被引 20)
- Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma (2021 · Cells · 被引 13)
- Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients (2021 · International Journal of Cancer · 被引 12)